<DOC>
	<DOCNO>NCT02734433</DOCNO>
	<brief_summary>This Phase 1 , non-randomized , open-label , multiple dose study pexidartinib Asian subject advance solid tumor . The study conduct dose escalation ass safety tolerability , PK PD , preliminary antitumor activity pexidartinib .</brief_summary>
	<brief_title>Study Pexidartinib Asian Subjects With Advanced Solid Tumors</brief_title>
	<detailed_description />
	<criteria>Age ≥ 20 year . Subjects must pathologically document solid tumor relapse , refractory standard treatment , standard treatment available . All associate toxicity previous cancer therapy must resolve ( ≤ Grade 1 ) prior administration pexidartinib . ECOG PS 0 1 . Adequate hematologic , hepatic , renal function test . Adequate treatment washout period registration define : Major surgery : ≥ 4 week ( 2 week less invasive surgery , colostomy ) Radiation therapy ( eg , whole brain radiotherapy ) : ≥ 4 week ( palliative stereotactic radiation therapy , ≥ 2 week ) Chemotherapy immunotherapy ( include target therapy antibody small molecule , retinoid therapy , hormonal therapy ) : 4 week 5 halflives agent , whichever short ( regimen contain nitrosoureas mitomycin C , ≥ 6 week ) Other investigational drug therapy : ≥ 4 week Refractory nausea vomiting , malabsorption , external biliary shunt , significant small bowel resection would preclude adequate absorption . Previous use pexidartinib biologic treatment target colony stimulate factor 1 ( CSF1 ) receptor colonystimulating factor1 ( CSF1R ) ; previous use oral tyrosine kinase inhibitor , eg , imatinib nilotinib , allow . Clinically active primary central nervous system tumor brain metastasis , define untreated symptomatic , require therapy steroid anticonvulsant control associate symptom . Active chronic infection hepatitis C know positive hepatitis B surface . antigen , know active chronic infection human immunodeficiency virus . A screening Fridericia correct QT interval ( QTcF ) ≥ 450 m ( men ) ≥ 470 m ( woman ) . A medical history complication clinically significant lung disease ( eg , interstitial pneumonia , pneumonitis , pulmonary fibrosis , severe radiation pneumonitis ) . A history symptomatic congestive heart failure ( [ CHF ] ; New York Heart Association [ NYHA ] Classes II IV ) serious cardiac arrhythmia require treatment . A history myocardial infarction unstable angina within 6 month enrollment . An uncontrolled infection require intravenous injection antibiotic , antiviral , antifungal .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Advanced solid tumor</keyword>
	<keyword>asian subject</keyword>
</DOC>